These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3243739)

  • 1. Pharmacokinetics and tissue penetration of cefpirome, a new cephalosporin.
    Kavi J; Andrews JM; Ashby JP; Hillman G; Wise R
    J Antimicrob Chemother; 1988 Dec; 22(6):911-6. PubMed ID: 3243739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and tissue penetration of cefepime.
    Nye KJ; Shi YG; Andrews JM; Wise R
    J Antimicrob Chemother; 1989 Jul; 24(1):23-8. PubMed ID: 2777727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and tissue penetration of cefprozil.
    Nye K; O'Neill P; Andrews JM; Wise R
    J Antimicrob Chemother; 1990 May; 25(5):831-5. PubMed ID: 2373665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and tissue penetration of ceftibuten.
    Wise R; Nye K; O'Neill P; Wostenholme M; Andrews JM
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1053-5. PubMed ID: 2393265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and tissue penetration of orally administered pefloxacin.
    Webberley JM; Andrews JM; Ashby JP; McLeod A; Wise R
    Eur J Clin Microbiol; 1987 Oct; 6(5):521-4. PubMed ID: 3481335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraperitoneal penetration of cefpirome.
    Kavi J; Ashby JP; Wise R; Donovan IA
    Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):556-8. PubMed ID: 2504599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and tissue penetration of ceftazidime: studies on lymph, aqueous humour, skin blister, cerebrospinal and pleural fluid.
    Walstad RA; Hellum KB; Blika S; Dale LG; Fredriksen T; Myhre KI; Spencer GR
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():275-82. PubMed ID: 6352632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacokinetics and inflammatory fluid penetration of orally administered azithromycin.
    Cooper MA; Nye K; Andrews JM; Wise R
    J Antimicrob Chemother; 1990 Oct; 26(4):533-8. PubMed ID: 2174853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and inflammatory fluid penetration of cefpodoxime proxetil in volunteers.
    O'Neill P; Nye K; Douce G; Andrews J; Wise R
    Antimicrob Agents Chemother; 1990 Feb; 34(2):232-4. PubMed ID: 2327771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Teicoplanin, its pharmacokinetics, blister and peritoneal fluid penetration.
    Wise R; Donovan IA; McNulty CA; Waldron R; Andrews JM
    J Hosp Infect; 1986 Mar; 7 Suppl A():47-55. PubMed ID: 2871097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefpirome clinical pharmacokinetics.
    Strenkoski LC; Nix DE
    Clin Pharmacokinet; 1993 Oct; 25(4):263-73. PubMed ID: 8261711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetics and tissue penetration of teicoplanin.
    McNulty CA; Garden GM; Wise R; Andrews JM
    J Antimicrob Chemother; 1985 Dec; 16(6):743-9. PubMed ID: 2936707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Skin penetration of sulfamethoxazole and trimethoprim after oral administration].
    Królicki A
    Ann Acad Med Stetin; 2002; 48():59-73. PubMed ID: 14601469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of cefpirome during continuous venovenous hemofiltration: rationale for an 8-hour dosing interval.
    Banyai M; Thalhammer F; El-Menyawi I; Heinz G; Traunmüller F; Siostrzonek P
    Clin Pharmacol Ther; 2000 Apr; 67(4):368-72. PubMed ID: 10801245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacokinetics and tissue penetration of ofloxacin.
    Lockley MR; Wise R; Dent J
    J Antimicrob Chemother; 1984 Dec; 14(6):647-52. PubMed ID: 6596301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid penetration of cefpirome in patients with non-inflamed meninges.
    Nix DE; Wilton JH; Velasquez N; Budny JL; Lassman HB; Mitchell P; Divan K; Schentag JJ
    J Antimicrob Chemother; 1992 Apr; 29 Suppl A():51-7. PubMed ID: 1601757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and suction blister fluid penetration of a semisynthetic injectable streptogramin RP 59500 (RP 57669/ RP 54476).
    Bernard E; Bensoussan M; Bensoussan F; Etienne S; Cazenave I; Carsenti-Etesse E; Le Roux Y; Montay G; Dellamonica P
    Eur J Clin Microbiol Infect Dis; 1994 Sep; 13(9):768-71. PubMed ID: 7843184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacokinetics and tissue penetration of intravenously administered CGP 31608.
    Wise R; Webberley JM; Andrews JM; Ashby JP
    J Antimicrob Chemother; 1988 Jan; 21(1):85-91. PubMed ID: 3356625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefodizime in skin suction blister fluid and serum following a single intravenous or intramuscular dose in adult patients.
    Mazzei T; Novelli A; Esposito S; Fallani S; Noviello S; Cassetta MI; Conti S; Periti P
    J Chemother; 2000 Aug; 12(4):306-13. PubMed ID: 10949980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low cefpirome levels during twice daily dosing in critically ill septic patients: pharmacokinetic modelling calls for more frequent dosing.
    Lipman J; Wallis SC; Rickard CM; Fraenkel D
    Intensive Care Med; 2001 Feb; 27(2):363-70. PubMed ID: 11396280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.